CN109464559A - A kind of traditional Chinese medicine plaster of resisting cardiovascular disease - Google Patents
A kind of traditional Chinese medicine plaster of resisting cardiovascular disease Download PDFInfo
- Publication number
- CN109464559A CN109464559A CN201811260275.3A CN201811260275A CN109464559A CN 109464559 A CN109464559 A CN 109464559A CN 201811260275 A CN201811260275 A CN 201811260275A CN 109464559 A CN109464559 A CN 109464559A
- Authority
- CN
- China
- Prior art keywords
- parts
- chinese medicine
- plaster
- cardiovascular disease
- traditional chinese
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 100
- 239000011505 plaster Substances 0.000 title claims abstract description 80
- 208000024172 Cardiovascular disease Diseases 0.000 title claims abstract description 43
- 239000000843 powder Substances 0.000 claims abstract description 82
- 239000004411 aluminium Substances 0.000 claims abstract description 54
- 229910052782 aluminium Inorganic materials 0.000 claims abstract description 54
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 claims abstract description 54
- 229920000747 poly(lactic acid) Polymers 0.000 claims abstract description 30
- 239000004626 polylactic acid Substances 0.000 claims abstract description 30
- 239000004744 fabric Substances 0.000 claims abstract description 25
- 239000003883 ointment base Substances 0.000 claims abstract description 24
- 239000004745 nonwoven fabric Substances 0.000 claims abstract description 20
- 239000000919 ceramic Substances 0.000 claims abstract description 18
- 239000006210 lotion Substances 0.000 claims abstract description 17
- 239000006247 magnetic powder Substances 0.000 claims abstract description 16
- 238000002360 preparation method Methods 0.000 claims abstract description 12
- 238000003756 stirring Methods 0.000 claims description 26
- 239000007788 liquid Substances 0.000 claims description 19
- 239000002253 acid Substances 0.000 claims description 13
- 239000006185 dispersion Substances 0.000 claims description 13
- 239000007787 solid Substances 0.000 claims description 13
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 11
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 claims description 10
- 229910052751 metal Inorganic materials 0.000 claims description 10
- 239000002184 metal Substances 0.000 claims description 10
- 239000003963 antioxidant agent Substances 0.000 claims description 9
- 230000003078 antioxidant effect Effects 0.000 claims description 9
- 229920000642 polymer Polymers 0.000 claims description 9
- 229920002725 thermoplastic elastomer Polymers 0.000 claims description 9
- 239000002131 composite material Substances 0.000 claims description 8
- 239000000314 lubricant Substances 0.000 claims description 8
- 239000004094 surface-active agent Substances 0.000 claims description 8
- RSWGJHLUYNHPMX-UHFFFAOYSA-N 1,4a-dimethyl-7-propan-2-yl-2,3,4,4b,5,6,10,10a-octahydrophenanthrene-1-carboxylic acid Chemical compound C12CCC(C(C)C)=CC2=CCC2C1(C)CCCC2(C)C(O)=O RSWGJHLUYNHPMX-UHFFFAOYSA-N 0.000 claims description 7
- 239000003795 chemical substances by application Substances 0.000 claims description 7
- 229920000742 Cotton Polymers 0.000 claims description 6
- KHPCPRHQVVSZAH-HUOMCSJISA-N Rosin Natural products O(C/C=C/c1ccccc1)[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 KHPCPRHQVVSZAH-HUOMCSJISA-N 0.000 claims description 6
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 claims description 6
- ZSWFCLXCOIISFI-UHFFFAOYSA-N cyclopentadiene Chemical compound C1C=CC=C1 ZSWFCLXCOIISFI-UHFFFAOYSA-N 0.000 claims description 6
- KHPCPRHQVVSZAH-UHFFFAOYSA-N trans-cinnamyl beta-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OCC=CC1=CC=CC=C1 KHPCPRHQVVSZAH-UHFFFAOYSA-N 0.000 claims description 6
- 244000144730 Amygdalus persica Species 0.000 claims description 5
- 244000061520 Angelica archangelica Species 0.000 claims description 5
- 241000489492 Arisaema Species 0.000 claims description 5
- 235000001287 Guettarda speciosa Nutrition 0.000 claims description 5
- 241000545744 Hirudinea Species 0.000 claims description 5
- 241000237636 Pheretima Species 0.000 claims description 5
- 235000006040 Prunus persica var persica Nutrition 0.000 claims description 5
- 244000046146 Pueraria lobata Species 0.000 claims description 5
- 235000010575 Pueraria lobata Nutrition 0.000 claims description 5
- 235000019484 Rapeseed oil Nutrition 0.000 claims description 5
- 229910000147 aluminium phosphate Inorganic materials 0.000 claims description 5
- 229920003180 amino resin Polymers 0.000 claims description 5
- 210000000941 bile Anatomy 0.000 claims description 5
- 239000002270 dispersing agent Substances 0.000 claims description 5
- -1 dodecane ester Chemical class 0.000 claims description 5
- 235000011803 sesame oil Nutrition 0.000 claims description 5
- 239000008159 sesame oil Substances 0.000 claims description 5
- SNRUBQQJIBEYMU-UHFFFAOYSA-N Dodecane Natural products CCCCCCCCCCCC SNRUBQQJIBEYMU-UHFFFAOYSA-N 0.000 claims description 4
- 239000004902 Softening Agent Substances 0.000 claims description 4
- 239000002671 adjuvant Substances 0.000 claims description 4
- 239000006071 cream Substances 0.000 claims description 4
- 239000000945 filler Substances 0.000 claims description 4
- 239000011159 matrix material Substances 0.000 claims description 4
- 239000003961 penetration enhancing agent Substances 0.000 claims description 4
- 238000001694 spray drying Methods 0.000 claims description 4
- 229920003002 synthetic resin Polymers 0.000 claims description 4
- 239000000057 synthetic resin Substances 0.000 claims description 4
- 229940099259 vaseline Drugs 0.000 claims description 4
- 235000015112 vegetable and seed oil Nutrition 0.000 claims description 4
- 239000008158 vegetable oil Substances 0.000 claims description 4
- WTVHAMTYZJGJLJ-UHFFFAOYSA-N (+)-(4S,8R)-8-epi-beta-bisabolol Natural products CC(C)=CCCC(C)C1(O)CCC(C)=CC1 WTVHAMTYZJGJLJ-UHFFFAOYSA-N 0.000 claims description 3
- RGZSQWQPBWRIAQ-CABCVRRESA-N (-)-alpha-Bisabolol Chemical compound CC(C)=CCC[C@](C)(O)[C@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-CABCVRRESA-N 0.000 claims description 3
- KSEBMYQBYZTDHS-HWKANZROSA-M (E)-Ferulic acid Natural products COC1=CC(\C=C\C([O-])=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-M 0.000 claims description 3
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 claims description 3
- 229920006465 Styrenic thermoplastic elastomer Polymers 0.000 claims description 3
- RGZSQWQPBWRIAQ-LSDHHAIUSA-N alpha-Bisabolol Natural products CC(C)=CCC[C@@](C)(O)[C@@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-LSDHHAIUSA-N 0.000 claims description 3
- 229940036350 bisabolol Drugs 0.000 claims description 3
- HHGZABIIYIWLGA-UHFFFAOYSA-N bisabolol Natural products CC1CCC(C(C)(O)CCC=C(C)C)CC1 HHGZABIIYIWLGA-UHFFFAOYSA-N 0.000 claims description 3
- 239000013530 defoamer Substances 0.000 claims description 3
- KSEBMYQBYZTDHS-HWKANZROSA-N ferulic acid Chemical compound COC1=CC(\C=C\C(O)=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-N 0.000 claims description 3
- 229940114124 ferulic acid Drugs 0.000 claims description 3
- KSEBMYQBYZTDHS-UHFFFAOYSA-N ferulic acid Natural products COC1=CC(C=CC(O)=O)=CC=C1O KSEBMYQBYZTDHS-UHFFFAOYSA-N 0.000 claims description 3
- 235000001785 ferulic acid Nutrition 0.000 claims description 3
- 239000000025 natural resin Substances 0.000 claims description 3
- 239000008188 pellet Substances 0.000 claims description 3
- 238000003672 processing method Methods 0.000 claims description 3
- 229910052710 silicon Inorganic materials 0.000 claims description 3
- 239000010703 silicon Substances 0.000 claims description 3
- QURCVMIEKCOAJU-UHFFFAOYSA-N trans-isoferulic acid Natural products COC1=CC=C(C=CC(O)=O)C=C1O QURCVMIEKCOAJU-UHFFFAOYSA-N 0.000 claims description 3
- 239000011787 zinc oxide Substances 0.000 claims description 3
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 claims description 2
- NOIWSPXMNWKZPJ-UHFFFAOYSA-N 2-bromo-1-butyl-3-methyl-2h-imidazole Chemical class CCCCN1C=CN(C)C1Br NOIWSPXMNWKZPJ-UHFFFAOYSA-N 0.000 claims description 2
- 239000004166 Lanolin Substances 0.000 claims description 2
- 239000004433 Thermoplastic polyurethane Substances 0.000 claims description 2
- 150000002313 glycerolipids Chemical class 0.000 claims description 2
- 229940039717 lanolin Drugs 0.000 claims description 2
- 235000019388 lanolin Nutrition 0.000 claims description 2
- 239000000787 lecithin Substances 0.000 claims description 2
- 235000010445 lecithin Nutrition 0.000 claims description 2
- 229940067606 lecithin Drugs 0.000 claims description 2
- 239000000203 mixture Substances 0.000 claims description 2
- 239000003921 oil Substances 0.000 claims description 2
- 235000019198 oils Nutrition 0.000 claims description 2
- 239000000344 soap Substances 0.000 claims description 2
- 238000004381 surface treatment Methods 0.000 claims description 2
- 229920002803 thermoplastic polyurethane Polymers 0.000 claims description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 claims 2
- FQJXITFHANYMET-UHFFFAOYSA-N 3-pentoxypropane-1,2-diol Chemical compound CCCCCOCC(O)CO FQJXITFHANYMET-UHFFFAOYSA-N 0.000 claims 1
- BAVYZALUXZFZLV-UHFFFAOYSA-O Methylammonium ion Chemical compound [NH3+]C BAVYZALUXZFZLV-UHFFFAOYSA-O 0.000 claims 1
- 150000001336 alkenes Chemical class 0.000 claims 1
- 229910021529 ammonia Inorganic materials 0.000 claims 1
- JEIPFZHSYJVQDO-UHFFFAOYSA-N iron(III) oxide Inorganic materials O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 claims 1
- 125000001972 isopentyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])C([H])([H])* 0.000 claims 1
- 239000011806 microball Substances 0.000 claims 1
- 229920002635 polyurethane Polymers 0.000 claims 1
- 239000004814 polyurethane Substances 0.000 claims 1
- 230000035699 permeability Effects 0.000 abstract description 18
- 229940079593 drug Drugs 0.000 abstract description 16
- 238000010521 absorption reaction Methods 0.000 abstract description 14
- 229920006264 polyurethane film Polymers 0.000 abstract description 13
- 238000010438 heat treatment Methods 0.000 abstract description 6
- 230000000844 anti-bacterial effect Effects 0.000 abstract description 4
- 230000000857 drug effect Effects 0.000 abstract description 4
- 230000002045 lasting effect Effects 0.000 abstract description 4
- 230000002269 spontaneous effect Effects 0.000 abstract description 4
- 230000000052 comparative effect Effects 0.000 description 24
- 239000010410 layer Substances 0.000 description 15
- 229920001971 elastomer Polymers 0.000 description 12
- 230000000694 effects Effects 0.000 description 11
- 239000007789 gas Substances 0.000 description 10
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 8
- 239000002002 slurry Substances 0.000 description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- 238000004026 adhesive bonding Methods 0.000 description 6
- 230000003115 biocidal effect Effects 0.000 description 6
- 239000003292 glue Substances 0.000 description 6
- 238000000034 method Methods 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- 238000002156 mixing Methods 0.000 description 5
- QZCLKYGREBVARF-UHFFFAOYSA-N Acetyl tributyl citrate Chemical compound CCCCOC(=O)CC(C(=O)OCCCC)(OC(C)=O)CC(=O)OCCCC QZCLKYGREBVARF-UHFFFAOYSA-N 0.000 description 4
- 239000004925 Acrylic resin Substances 0.000 description 4
- 244000020518 Carthamus tinctorius Species 0.000 description 4
- 235000003255 Carthamus tinctorius Nutrition 0.000 description 4
- RRHGJUQNOFWUDK-UHFFFAOYSA-N Isoprene Chemical compound CC(=C)C=C RRHGJUQNOFWUDK-UHFFFAOYSA-N 0.000 description 4
- 235000021355 Stearic acid Nutrition 0.000 description 4
- 230000017531 blood circulation Effects 0.000 description 4
- 239000004568 cement Substances 0.000 description 4
- 230000002526 effect on cardiovascular system Effects 0.000 description 4
- 235000019441 ethanol Nutrition 0.000 description 4
- 239000012046 mixed solvent Substances 0.000 description 4
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 4
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 4
- 229920005646 polycarboxylate Polymers 0.000 description 4
- 239000008117 stearic acid Substances 0.000 description 4
- 230000008961 swelling Effects 0.000 description 4
- 229920000178 Acrylic resin Polymers 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 210000004204 blood vessel Anatomy 0.000 description 3
- 235000010354 butylated hydroxytoluene Nutrition 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 238000004090 dissolution Methods 0.000 description 3
- 239000001257 hydrogen Substances 0.000 description 3
- 229910052739 hydrogen Inorganic materials 0.000 description 3
- 230000003647 oxidation Effects 0.000 description 3
- 238000007254 oxidation reaction Methods 0.000 description 3
- 238000012545 processing Methods 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- 238000009738 saturating Methods 0.000 description 3
- 240000008886 Ceratonia siliqua Species 0.000 description 2
- 235000013912 Ceratonia siliqua Nutrition 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- 238000001467 acupuncture Methods 0.000 description 2
- 239000000853 adhesive Substances 0.000 description 2
- 230000001070 adhesive effect Effects 0.000 description 2
- 239000002518 antifoaming agent Substances 0.000 description 2
- 208000026106 cerebrovascular disease Diseases 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 230000008451 emotion Effects 0.000 description 2
- 238000000265 homogenisation Methods 0.000 description 2
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 2
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 2
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 2
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 2
- 238000007654 immersion Methods 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- XKBGEWXEAPTVCK-UHFFFAOYSA-M methyltrioctylammonium chloride Chemical compound [Cl-].CCCCCCCC[N+](C)(CCCCCCCC)CCCCCCCC XKBGEWXEAPTVCK-UHFFFAOYSA-M 0.000 description 2
- 230000004089 microcirculation Effects 0.000 description 2
- 239000002105 nanoparticle Substances 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 238000010074 rubber mixing Methods 0.000 description 2
- 150000003384 small molecules Chemical class 0.000 description 2
- 239000002344 surface layer Substances 0.000 description 2
- 208000019553 vascular disease Diseases 0.000 description 2
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 1
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 208000034530 PLAA-associated neurodevelopmental disease Diseases 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 238000013475 authorization Methods 0.000 description 1
- 150000003851 azoles Chemical class 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 230000002060 circadian Effects 0.000 description 1
- 238000005253 cladding Methods 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 238000005260 corrosion Methods 0.000 description 1
- 230000007797 corrosion Effects 0.000 description 1
- 238000000151 deposition Methods 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 239000004815 dispersion polymer Substances 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 229960005150 glycerol Drugs 0.000 description 1
- 230000005484 gravity Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 150000002431 hydrogen Chemical class 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 238000011031 large-scale manufacturing process Methods 0.000 description 1
- 210000003141 lower extremity Anatomy 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000004005 microsphere Substances 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 210000002464 muscle smooth vascular Anatomy 0.000 description 1
- 230000001114 myogenic effect Effects 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000002537 thrombolytic effect Effects 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 210000001364 upper extremity Anatomy 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 239000002759 woven fabric Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/62—Leeches; Worms, e.g. cestodes, tapeworms, nematodes, roundworms, earth worms, ascarids, filarias, hookworms, trichinella or taenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
- A61K35/64—Insects, e.g. bees, wasps or fleas
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/236—Ligusticum (licorice-root)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/286—Carthamus (distaff thistle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/488—Pueraria (kudzu)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/65—Paeoniaceae (Peony family), e.g. Chinese peony
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/69—Polygalaceae (Milkwort family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/736—Prunus, e.g. plum, cherry, peach, apricot or almond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/888—Araceae (Arum family), e.g. caladium, calla lily or skunk cabbage
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/888—Araceae (Arum family), e.g. caladium, calla lily or skunk cabbage
- A61K36/8884—Arisaema, e.g. Jack in the pulpit
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N2/00—Magnetotherapy
- A61N2/002—Magnetotherapy in combination with another treatment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N2/00—Magnetotherapy
- A61N2/06—Magnetotherapy using magnetic fields produced by permanent magnets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
- A61M2037/0007—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin having means for enhancing the permeation of substances through the epidermis, e.g. using suction or depression, electric or magnetic fields, sound waves or chemical agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/05—General characteristics of the apparatus combined with other kinds of therapy
- A61M2205/051—General characteristics of the apparatus combined with other kinds of therapy with radiation therapy
- A61M2205/052—General characteristics of the apparatus combined with other kinds of therapy with radiation therapy infrared
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/05—General characteristics of the apparatus combined with other kinds of therapy
- A61M2205/057—General characteristics of the apparatus combined with other kinds of therapy with magnetotherapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/0658—Radiation therapy using light characterised by the wavelength of light used
- A61N2005/0659—Radiation therapy using light characterised by the wavelength of light used infrared
- A61N2005/066—Radiation therapy using light characterised by the wavelength of light used infrared far infrared
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Medical Informatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Radiology & Medical Imaging (AREA)
- Inorganic Chemistry (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Insects & Arthropods (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Dermatology (AREA)
- Anesthesiology (AREA)
- Hematology (AREA)
- Pathology (AREA)
- Animal Husbandry (AREA)
- Tropical Medicine & Parasitology (AREA)
- Zoology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Preparation (AREA)
Abstract
The present invention relates to plaster technical fields, disclose a kind of traditional Chinese medicine plaster of resisting cardiovascular disease.The traditional Chinese medicine plaster of the resisting cardiovascular disease includes the plaster base fabric of Chinese medicine lotion and carrying Chinese medicine lotion.The Chinese medicine lotion includes the Chinese medicine of 19.5 ~ 20.2wt% and the ointment bases of 79.8 ~ 80.5wt%.The plaster base fabric includes outer layer made of internal layer made of polylactic acid non-woven fabrics and polyurethane film.And there are the microballoon, far-infared ceramic powder and magnetic powder of aluminium powder in ointment bases comprising load.Biocompatibility, the good permeability of the traditional Chinese medicine plaster of resisting cardiovascular disease of the invention, energy spontaneous heating, energy antibacterial waterproof, drug effect is fast, volatile performance is low, lasting medicine is good, and preparation process is simple.Solve the problems, such as that the traditional Chinese medicine plaster poor air permeability of current resisting cardiovascular disease, Yi Zhimin, drug absorption efficiency are poor.
Description
Technical field
The present invention relates to plaster technical field more particularly to a kind of traditional Chinese medicine plasters of resisting cardiovascular disease.
Background technique
Cardiovascular and cerebrovascular disease is the general designation of cardiovascular and cranial vascular disease, is a kind of to seriously threaten human life and health
Disease.Traditional common medicine for the treatment of cardio-cerebralvascular patient has Chinese medicine, Chinese patent drug, capsule, tablet, injection etc..Traditional note
It is big administration modes toxicity caused by body such as to penetrate, take orally, and drug reaches whole body by blood circulation, really reaching key portion
The dose of position is few.Plaster is avoided that endo-medicine bring toxic side effect, and drug effect is high, it is obvious to take effect.However, existing plaster exists
Problem used below: one, plaster absorption efficiency is low, medication cycle is long；Two, plaster thickness is thin, bad adhesion, and plaster covering is such as
The packaging effect of peeling paper etc. is bad and easy dampness；Three, plaster poor air permeability.
Chinese patent Authorization Notice No. is the patent of CN101912493B, discloses and a kind of treats cardio-cerebralvascular diseases cave
Position emplastrum.The acupoint plaster is made of head acupuncture point emplastrum, upper limb acupoint plaster and lower limb acupoint plaster, in use, three kinds of medicines
Emplastrum is affixed on corresponding acupuncture point simultaneously respectively.Acupoint plaster performance is stablized, easy to use, safe.However, the acupoint plaster is saturating
Gas, waterproof, antibiotic property are poor, and drug absorption efficiency is to be improved.
Summary of the invention
In order to solve the above-mentioned technical problems, the present invention provides a kind of traditional Chinese medicine plasters of resisting cardiovascular disease.This hair
Traditional Chinese medicine plaster biocompatibility, the good permeability of bright resisting cardiovascular disease, can spontaneous heating, can antibacterial waterproof, drug effect is fast,
Volatile performance is low, lasting medicine is good, and preparation process is simple.
The specific technical proposal of the invention is: a kind of traditional Chinese medicine plaster of resisting cardiovascular disease, the resisting cardiovascular
The traditional Chinese medicine plaster of disease includes the plaster base fabric of Chinese medicine lotion and carrying Chinese medicine lotion；The Chinese medicine lotion includes Chinese medicine mixing paste
Body matrix has the microballoon of aluminium powder in the ointment bases comprising load；The plaster base fabric includes made of polylactic acid non-woven fabrics
Outer layer made of internal layer and polyurethane film.
In the prior art, traditional Chinese medicine plaster surface layer is mostly made of acrylic resin or cotton.Although polyacrylic resin is malicious
The small, biocompatibility of property is also preferable, but after long-time use, will also result in patient skin redness itch.The good permeability of cotton,
But cotton is non-watertight, and the gap between cotton channels and collaterals is big, there is a problem of that ointment exudation, smell are pungent.
The plaster base fabric of the traditional Chinese medicine plaster of resisting cardiovascular disease of the invention is by polylactic acid non-woven fabrics and thin polyurethane
Film is made, and wherein polylactic acid non-woven fabrics is internal layer, and when use and skin contact, polyurethane film are outer layer, being capable of effective waterproof.
Plaster base fabric good permeability of the invention, good biocompatibility directly will not generate adverse reaction with skin contact, in addition, cream
The polylactic acid of medicine base fabric internal layer has natural anti-mite bacteriostasis, and pH and skin are close, can discharge go on a tour in use
From small molecule, the small molecule have extremely strong penetration power, with the lactic acid of this province of skin ining conjunction with after can not only effectively it is antibacterial,
The absorption efficiency of effective component in the traditional Chinese medicine plaster of the resisting cardiovascular disease can also be improved.Polylactic acid non-woven fabrics it is porous
Structure can allow air and water vapo r transmission, good permeability, and usage comfort is high.However, just because of polylactic acid non-woven fabrics it is ventilative,
Good water permeability causes its waterproofness very poor.In order to solve the disadvantage of polylactic acid non-woven fabrics waterproofness difference, the present invention polylactic acid without
Polyurethane film is provided on the outside of woven fabric.The waterproof performance of polyurethane film is excellent, while good permeability.By polylactic acid nonwoven
The plaster base fabric that cloth and polyurethane film collectively constitute not only has excellent ventilative, waterproof performance, while this can be promoted anti-
The absorption of effective component in the traditional Chinese medicine plaster of cardiovascular and cerebrovascular disease.
There is the microballoon of aluminium powder in ointment bases of the invention comprising load, when the Traditional Chinese medicine plaster using the resisting cardiovascular disease
When paste, the moisture in skin can enter microballoon and react with aluminium powder, generate hydrogen, while releasing heat.Due to depositing for microballoon
The reaction slowly occurs, and can continue to release hydrogen and heat.Hydrogen enters after skin the activity that can be improved cell, micro-
Heat can also improve cell activity, promote blood circulation, and then effective component in the traditional Chinese medicine plaster of promotion resisting cardiovascular disease
Absorption.
Preferably, the microballoon includes aluminium powder and the polylactic acid shell that is coated on outside aluminium powder.
The shell of microballoon of the invention is polylactic acid, and polylactic acid is permeable, good permeability, moisture content can not be made to enter microballoon
It is reacted with aluminium powder, while the gas permeability of ointment bases can be increased, improve the saturating of the traditional Chinese medicine plaster of the resisting cardiovascular disease
Gas and usage comfort.
Preferably, containing solid weak acid in the aluminium powder, the mass ratio of aluminium powder and solid weak acid is 4~10:1.
Contain a small amount of solid weak acid in aluminium powder of the invention, the oxidation on aluminium powder surface layer can be effectively prevent, enable aluminium powder
Enough lasting reacts with water.
Preferably, the microballoon the preparation method comprises the following steps:
A) according to parts by weight, the acetone soln that solid content is 8~12wt% is made in 78~82 parts of polylactic acid under room temperature, be added
0.08~0.12 part of phosphoric acid, is dispersed with stirring 10~25min；14~18 parts of surface is slowly added into dispersion liquid while stirring
2.4~2.6 parts of amino resins, 0.4~0.6 part of organic silicon defoamer and 0.8~1.0 is added in the aluminium powder of processing while stirring
Part polycarboxylate dispersant continues to stir 30-120min, obtains the composite dispersion liquid of polymer-coated metal powder；
B) the obtained composite dispersion liquid of step a) is spray-dried, obtains the microballoon of polymer-coated metal powder.
Method for preparing microsphere of the invention is simple, is suitble to large-scale production.Wherein phosphoric acid is as antioxygen corrosion inhibiter, Neng Goufang
Only aluminium powder oxidation.Amino resins is used to form polymer overmold aluminium powder as curing agent, and then forms microballoon.Organosilicon defoaming
Agent can eliminate the bubble generated in whipping process, keep liquid uniform.Polycarboxylate dispersant can make aluminium powder fully dispersed and aqueous
Polymer dispersion liquid cladding.
Preferably, the aluminium powder of the surface treatment is that metal powder passes through lubricant or/and surfactant in step a)
What processing obtained, processing method are as follows: the lubricant or/and surfactant solution that concentration is 0.4~0.6wt% is added in aluminium powder
Middle 15~25min of ultrasonic disperse, then in 55~65 DEG C of 2~3h of stirring, aluminium powder and lubricant or/and surfactant solution
Mass volume ratio is 1:3~5；The lubricant is at least one of stearic acid, metallic soap and atoleine, and the surface is living
Property agent be at least one of neopelex, lecithin and fatty acid sorbitan；In step b), the spray drying
Intake air temperature be 170-250 DEG C；Air outlet temperature is 70-100 DEG C.
The present invention is needed when preparing microballoon with lubricator or/and surfactant handles aluminium powder, to prevent aluminium
Powder ball is poly-, increases dispersibility of the aluminium powder in dispersion liquid.
Preferably, the mass percent of the Chinese medicine and ointment bases are as follows: Chinese medicine 19.5~20.2%, ointment bases
79.8~80.5%.
The weight percent of Chinese medicine and ointment bases is respectively as follows: in the traditional Chinese medicine plaster of resisting cardiovascular disease of the invention
19.5~20.2% and 79.8~80.5%.Chinese medicine proportion is excessive, will lead to the active principle in effective application time
It absorbs endless, causes to waste.The specific gravity of Chinese medicine is very few to be will be unable to reach ideal effect.
Preferably, the ointment bases include the composition of following parts by weight: 39~46 parts of medical thermoplastic elastomer (TPE),
15~29 parts of medical tackifier, 1~5 part of skin penetration enhancer, load the microballoon 7 for having aluminium powder at 20~38 parts of medical softening agent
~10 parts, 4~7 parts of filler zinc oxide, 0.6~1 part of far-infared ceramic powder, 7~8 parts of magnetic powder and 1~2 part of antioxidant.
Contain antioxidant in ointment bases of the invention, to prevent the oxidation of effective component.In addition, also containing in ointment bases
There is load to have the microballoon, far-infared ceramic powder and magnetic powder of aluminium powder.Load has the microballoon of aluminium powder that can increase the saturating of ointment bases
Gas, while the absorption of effective component in Chinese medicine can be promoted.Far-infared ceramic powder can give off more more than normal object
Far infrared, can active cell, relaxation vascular smooth muscle, enhancing blood vessel own circadian movement, so as to improve microcirculation in human body,
It boosts metabolism, balances body pH value and Repercusion analgesia.During far-infared ceramic powder and magnetic powder collocation can significantly increase
The absorption of pharmaceutically active ingredient.
Preferably, the Chinese medicine includes following components: 12-14 parts of Radix Angelicae Sinensis, 8-10 parts of Rhizoma Chuanxiong, 8-10 parts of leech, Eupolyphoge sinensis
8-10 parts, 4-6 parts of radix paeoniae rubra, 4-6 parts of peach kernel, 6-8 parts of safflower, 12-14 parts of pheretima, 7-9 parts of pueraria lobata, 18-20 parts of the root of Dahurain angelica, rhizoma acori graminei
10-12 parts, 10-12 parts of Radix Polygalae, 7-9 parts of rhizoma typhonii, 5-7 parts of arisaema cum bile, 5-8 parts of bombys batryticatus, 200-280 parts of wide pellet and vegetable oil
460-540 parts.
Include the drug of dredging the channel, activating microcirculation and removing stasis medicinal in Chinese medicine of the invention, also includes calm emotions, dispelling wind and relieving convulsion
The drug of drug and myogenic promoting blood circulation.Radix Angelicae Sinensis in drug of the invention, Rhizoma Chuanxiong, leech, Eupolyphoge sinensis, radix paeoniae rubra, peach kernel, safflower, pheretima and
Pueraria lobata all has effect promoting blood circulation and removing obstruction in channels, can promote the dissolution of thrombus, prevents the accumulation of fat.The root of Dahurain angelica has blood activating and promoting tissue regeneration
Effect, can promote the reparative regeneration of blood vessel, help to restore blood vessel elasticity.Rhizoma acori graminei, Radix Polygalae, rhizoma typhonii, arisaema cum bile and deadlock
Worm being capable of calm emotions.Chinese medicine compounding of the invention can stabilize the mind of user, promote thrombolysis and enhance vascular wall
Elasticity.
Preferably, the antioxidant is antioxidant BHT.The thermoplastic elastomer be styrenic thermoplastic elastomer,
At least one of polyester-type thermoplastic rubber, thermoplastic polyurethane；The tackifier are natural or synthetic resin, the day
So or synthetic resin is at least one of cyclopentadiene, isoprene, rosin, hydrogenated rosin, hydrogenated rosin glycerolipid；It is described
Softening agent be at least one of atoleine, lanolin, yellow petroleum jelly, vaseline；The skin penetration enhancer includes
Host agent and adjuvant, the host agent are N- dimethylamino n-butyric acie dodecane ester and bisabolol, ferulic acid and glycerol list penta
At least one of ether, the adjuvant are at least one in tri-n-octyl methyl ammonium chloride and bromo 1- butyl -3- methyl-imidazoles
Kind.
Preferably, the vegetable oil is at least one of sesame oil, rapeseed oil, cotton oil.
It is compared with the prior art, the beneficial effects of the present invention are: the traditional Chinese medicine plaster of resisting cardiovascular disease of the invention
There is the microballoon, remote of aluminium powder comprising load using polylactic acid non-woven fabrics and polyurethane film as plaster base fabric, and in ointment bases
Infrared ceramic powder and magnetic powder.Biocompatibility, the good permeability of the traditional Chinese medicine plaster of resisting cardiovascular disease of the invention, energy
Spontaneous heating, energy antibacterial waterproof, drug effect is fast, volatile performance is low, lasting medicine is good, and preparation process is simple.
Specific embodiment
The present invention will be further described with reference to the examples below.Related device, connection structure in the present invention
And method, if being device well known in the art, connection structure and method without refering in particular to.
Embodiment 1
A kind of traditional Chinese medicine plaster of resisting cardiovascular disease, the traditional Chinese medicine plaster including the resisting cardiovascular disease include Chinese medicine
The plaster base fabric of lotion and carrying Chinese medicine lotion；The Chinese medicine lotion includes the Chinese medicine of 19.8wt% and the lotion base of 80.2wt%
Matter has the microballoon of aluminium powder in the ointment bases comprising load；The plaster base fabric includes made of polydactyl acid non-woven fabrics
Outer layer made of internal layer and polyurethane film.
Microballoon the preparation method comprises the following steps:
A) acetone soln that solid content is 10wt% is made in 80 parts of polylactic acid under room temperature, 0.1 part of phosphoric acid is added, is dispersed with stirring
18min；16 parts of aluminium powders containing solid weak acid handled by stearic acid, aluminium are slowly added into dispersion liquid while stirring
The mass ratio of powder and solid weak acid is 7:1, and 2.5 parts of amino resins, 0.5 part of organic silicon defoamer and 0.9 are added while stirring
Part polycarboxylate dispersant continues to stir 75min, obtains the composite dispersion liquid of polymer-coated metal powder；Wherein, the processing side of aluminium powder
Method are as follows: ultrasonic disperse 20min in the stearic acid solution that concentration is 0.5wt% is added in aluminium powder, then in 60 DEG C of stirring 2.5h, aluminium
The mass volume ratio of powder and stearic acid solution is 1:4；
B) the obtained composite dispersion liquid of step a) is spray-dried, the intake air temperature of spray drying is 210 DEG C；Air outlet
Temperature is 85 DEG C, obtains the microballoon of polymer-coated metal powder.
Polydactyl acid non-woven fabrics the preparation method comprises the following steps: PLA and FP is dried 4h at 80 DEG C, then, by PLA, FP and
Ratio of the ATBC with mass ratio for 92:3:5 is squeezed out in double screw extruder, is granulated, and extruder temperature is 190 DEG C, and revolving speed is
130rpm obtains PLA, FP and ATBC blended particles；PLA, FP and ATBC blended particles are dried at 80 DEG C carry out after 4h it is spunbond
Nonwoven cloth mesh-bar placement obtains the polylactic acid non-woven fabrics of toughening modifying.
Polylactic acid non-woven fabrics is modified with FP and ATBC, and toughness dramatically increases, and anti-bursting and lear energy significantly increases.
The toughness of the plaster base fabric of modified polylactic acid non-woven fabrics preparation is strong, after use, removes conveniently.
A kind of preparation method of the traditional Chinese medicine plaster of resisting cardiovascular disease the following steps are included:
(1) glue: by 42 parts of styrenic thermoplastic elastomers, 22 parts of cyclopentadiene, 1.5 parts of antioxidant BHTs, 0.8 part of far infrared
Ceramic powder, 7.5 parts of magnetic powders throw and obtain the rubber sheet of 0.9mm thickness in rubber mixing machine roll-in, are subsequently placed in blender and are added
The mixed solvent of the ethyl alcohol of the gasoline and 18wt% of 82wt% carries out immersion swelling, the mass ratio of rubber sheet and mixed solvent
For 1:8.
(2) ingredient: 240 parts wide pellet being dissolved in 500 parts of sesame oil and is stirred evenly, by 13 parts of Radix Angelicae Sinensis, 9 parts of Rhizoma Chuanxiongs, 9 parts of water
Leech, 9 parts of Eupolyphoge sinensis, 5 parts of radix paeoniae rubras, 5 parts of peach kernels, 7 parts of safflowers, 13 parts of pheretimas, 8 parts of pueraria lobatas, 19 parts of roots of Dahurain angelica, 11 parts of rhizoma acori gramineis, 11 parts
Radix Polygalae, 8 parts of rhizoma typhoniis, 6 parts of arisaema cum bile, 6 portions of bombys batryticatus, which are ground to be added in sesame oil after nano-scale particle, stirs evenly dissolution, by 1
Part N- dimethylamino n-butyric acie dodecane ester, 1 part of bisabolol, 1 part of tri-n-octyl methyl ammonium chloride, 5.5 parts of filler oxygen
Change zinc, 29 parts of vaseline sequentially add and are uniformly mixing to obtain mixed liquor in sesame oil.
(3) it is beaten: the rubber sheet after swelling being cut into the rubber segments that length is less than 1cm, adhesive supplier is put into, is then added
It mixes feed liquid and stirs gluing, be sieved to obtain rubber cement through sieve, the feed liquid that sieve retains is again returned into gluing.
(4) it is homogenized: rubber cement being sent into high-shear homogenizer with the revolving speed homogenization of 9000r/min, slurry is obtained, to slurry
9 parts of loads are added in material has the microballoon of aluminium powder to stir evenly, and obtains the slurry containing microballoon.
(5) gluing: plaster base fabric being sent into two roll-in cylinders of glue spreader, is added the slurry containing microballoon to glue spreader and is applied
It overlays on plaster base fabric and paste is made.
(6) spool: heating beamer, and temperature is respectively as follows: 60 DEG C of first of oven temperature at each baking oven in control beamer,
90 DEG C of second oven temperature, 70 DEG C of third road oven temperature handles paste spool.
(7) paster: peeling paper is closed in the plaster face paste of paste, in peeling paper outer application volatilization trapping layer, volatilization is prevented
Layer is sprayed by the component mixing of following parts by weight: 7 parts of hydroxypropyl methyl cellulose, 3 parts of carob, 50 parts of ethyl alcohol, water
75 parts, thickness is 3 μm.
(8) encapsulate: bagging encapsulates to obtain the traditional Chinese medicine plaster of resisting cardiovascular disease after being sliced by predetermined size.
Embodiment 2
A kind of traditional Chinese medicine plaster of resisting cardiovascular disease, the traditional Chinese medicine plaster including the resisting cardiovascular disease include Chinese medicine
The plaster base fabric of lotion and carrying Chinese medicine lotion；The Chinese medicine lotion includes the Chinese medicine of 19.5wt% and the lotion base of 80.5wt%
Matter has the microballoon of aluminium powder in the ointment bases comprising load；The plaster base fabric includes internal layer made of polylactic acid non-woven fabrics
With outer layer made of polyurethane film.
Microballoon the preparation method comprises the following steps:
A) acetone soln that solid content is 8wt% is made in 78 parts of polylactic acid under room temperature, 0.08 part of phosphoric acid is added, is dispersed with stirring
10min；Be slowly added to while stirring into dispersion liquid 14 parts by neopelex handle containing solid it is weak
The mass ratio of the aluminium powder of acid, aluminium powder and solid weak acid is 4:1, the amino resins, 0.4 part of organosilicon of 2.4 parts of addition while stirring
Defoaming agent and 0.8 part of polycarboxylate dispersant continue to stir 30min, obtain the composite dispersion liquid of polymer-coated metal powder；Wherein,
The processing method of aluminium powder are as follows: ultrasonic disperse in the neopelex solution that concentration is 0.4wt% is added in aluminium powder
25min, then in 65 DEG C of stirring 2h, the mass volume ratio of aluminium powder and neopelex solution is 1:5；
B) the obtained composite dispersion liquid of step a) is spray-dried, the intake air temperature of spray drying is 170 DEG C；Air outlet
Temperature is 70 DEG C, obtains the microballoon of polymer-coated metal powder.
A kind of preparation method of the traditional Chinese medicine plaster of resisting cardiovascular disease the following steps are included:
(1) glue: by 39 parts of polyester-type thermoplastic rubber, 15 parts of isoprene, 1 part of antioxidant BHT, 0.6 part of far-infrared ceramic
Powder, 7 parts of magnetic powders are thrown and obtain the rubber sheet of 0.13mm thickness in rubber mixing machine roll-in, are subsequently placed in blender and 95wt% is added
Gasoline and 5wt% ethyl alcohol mixed solvent, carry out immersion swelling, the mass ratio of rubber sheet and mixed solvent is 1:10.
(2) ingredient: wide red 200 parts being dissolved in 460 parts of rapeseed oil and is stirred evenly, by 12 parts of Radix Angelicae Sinensis, 8 parts of Rhizoma Chuanxiongs, 9 parts of water
Leech, 9 parts of Eupolyphoge sinensis, 4 parts of radix paeoniae rubras, 4 parts of peach kernels, 6 parts of safflowers, 12 parts of pheretimas, 7 parts of pueraria lobatas, 18 parts of roots of Dahurain angelica, 10 parts of rhizoma acori gramineis, 10 parts
Radix Polygalae, 7 parts of rhizoma typhoniis, 5 parts of arisaema cum bile, 5 portions of bombys batryticatus, which are ground to be added in rapeseed oil after nano-scale particle, stirs evenly dissolution, general
0.5 part of N- dimethylamino n-butyric acie dodecane ester of transdermal enhancer, 0.2 part of ferulic acid, 0.3 part of bromo 1- butyl -3- methyl-miaow
Azoles, 4 parts of filler zinc oxide, 20 parts of atoleines sequentially add and are uniformly mixing to obtain mixed liquor in rapeseed oil.
(3) it is beaten: the rubber sheet after swelling being cut into the rubber segments that length is less than 1cm, then is put into adhesive supplier, then
It is added and mixes feed liquid stirring gluing, be sieved to obtain rubber cement through sieve, the feed liquid that sieve retains is again returned into gluing.
(4) it is homogenized: rubber cement being sent into high-shear homogenizer, revolving speed 8000r/min homogenization is kept to obtain slurry, to slurry
7 parts of loads are added in material has the microballoon of aluminium powder to stir evenly, and obtains the slurry containing microballoon.
(5) gluing: plaster base fabric being sent into two roll-in cylinders of glue spreader, is added the slurry containing microballoon to glue spreader and is applied
It overlays on plaster base fabric and paste is made.
(6) spool: heating beamer, and temperature is respectively as follows: 55 DEG C of first of oven temperature at each baking oven in control beamer,
85 DEG C of second oven temperature, 65 DEG C of third road oven temperature handles paste spool.
(7) paster: peeling paper is closed in the plaster face paste of paste, in peeling paper outer application volatilization trapping layer, volatilization is prevented
Layer is sprayed by the component mixing of following parts by weight: 4 parts of hydroxypropyl methyl cellulose, 10 parts of carob, 40 parts of ethyl alcohol, water 60
Part, thickness is 5 μm.
(8) encapsulate: bagging encapsulates to obtain the traditional Chinese medicine plaster of resisting cardiovascular disease after being sliced by predetermined size.
Embodiment 3
Embodiment 3 difference from example 1 is that: the plaster base fabric packet of the traditional Chinese medicine plaster of the resisting cardiovascular disease
Include outer layer made of internal layer made of polylactic acid non-woven fabrics and polyurethane film.Other are same as Example 1.
Comparative example 1
Comparative example 1 difference from example 1 is that: not including load in the ointment bases of comparative example 1 has the microballoon of aluminium powder,
The amount of microballoon missing is supplied with far-infared ceramic powder.Other are identical as example 1.
Comparative example 2
Comparative example 2 difference from example 1 is that: in the ointment bases of comparative example 2 do not include magnetic powder, magnetic powder missing
Amount supplied with far-infared ceramic powder.Other are identical as example 1.
Comparative example 3
Comparative example 3 difference from example 1 is that: not packet far-infared ceramic powder in the ointment bases of comparative example 3, far infrared
The amount of ceramic powder missing is supplied with magnetic powder.Other are identical as example 1.
Comparative example 4
Comparative example 4 difference from example 1 is that: not packet magnetic powder and far-infrared ceramic in the ointment bases of comparative example 4
The amount of powder, magnetic powder and far-infared ceramic powder missing is supplied with microballoon.Other are identical as example 1.
Comparative example 5
Comparative example 5 difference from example 1 is that: the plaster base fabric of comparative example 4 selects acrylic resin non-woven fabrics to replace
Polylactic acid non-woven fabrics and polyurethane film.Other are identical as example 1.
To gas permeability, the waterproof of the traditional Chinese medicine plaster of the resisting cardiovascular disease of Examples 1 to 3 and the preparation of comparative example 1~5
Property, antibiotic property, drug absorption efficiency and removal peeling paper 15min after emplastrum surface temperature detected.Test result such as table 1
It is shown.
Table 1
| Group number | Gas permeability | Waterproofness | Emplastrum surface temperature (DEG C) | Drug absorption efficiency (%) | Antibiotic property |
| Embodiment 1 | It is excellent | It is excellent | 40.3 | 90.2 | It is sterile |
| Embodiment 2 | It is excellent | It is excellent | 40.2 | 89.5 | It is sterile |
| Embodiment 3 | It is excellent | It is excellent | 40.2 | 89.9 | It is sterile |
| Comparative example 1 | It is good | It is excellent | 26.6 | 55.4 | It is sterile |
| Comparative example 2 | It is good | It is excellent | 29.1 | 56.3 | It is sterile |
| Comparative example 3 | It is good | It is excellent | 27.9 | 50.6 | It is sterile |
| Comparative example 4 | It is excellent | It is excellent | 31.3 | 58.1 | It is sterile |
| Comparative example 5 | In | In | 40.3 | 57.6 | There is bacterium |
As can be seen from Table 1, the traditional Chinese medicine plaster of resisting cardiovascular disease of the invention have excellent gas permeability, waterproofness,
Antibiotic property and excellent drug absorption efficiency, emplastrum surface temperature reaches 40 DEG C after removing peeling paper 15min.Comparative example 1
In~3, the load in ointment bases there are into any one removal in the microballoon, far-infared ceramic powder or magnetic powder of aluminium powder, patch
The gas permeability of paste is deteriorated, and the surface temperature and drug absorption efficiency of emplastrum all significantly decrease.In comparative example 4, by cream
Magnetic powder and far-infared ceramic powder in body matrix have the microballoon of aluminium powder to replace with load, and the surface temperature and drug of emplastrum are inhaled
Rate of producing effects all significantly decreases.Illustrate that the load in ointment bases has the microballoon of aluminium powder, far-infared ceramic powder and magnetic powder
Effect is not simply to sum it up, but have complementary synergistic effect, can obtain unexpected effect.Comparative example
In 5, plaster base fabric made of polylactic acid non-woven fabrics and polyurethane film is replaced with acrylic resin non-woven fabrics, the anti-heart obtained
Gas permeability, waterproofness and the antibiotic property of the traditional Chinese medicine plaster of cranial vascular disease significantly reduce, and the absorption efficiency of drug also obviously drops
It is low.Therefore, it is excellent that gas permeability, waterproofness, antibiotic property can be just obtained only within the scope of restriction of the invention, it can spontaneous heating and medicine
The traditional Chinese medicine plaster of the high resisting cardiovascular disease of object absorption efficiency.
The above is only the preferred embodiment of invention, is not intended to limit the invention in any way, all skills according to the present invention
Art any simple modification, change and equivalent structure transformation substantially to the above embodiments, still fall within the technology of the present invention
The protection scope of scheme.
Claims (10)
1. a kind of traditional Chinese medicine plaster of resisting cardiovascular disease, it is characterised in that: the Chinese medicinal plaster of the resisting cardiovascular disease
Agent includes the plaster base fabric of Chinese medicine lotion and carrying Chinese medicine lotion；The Chinese medicine lotion includes Chinese medicine and ointment bases, the cream
There is the microballoon of aluminium powder in body matrix comprising load；The plaster base fabric includes internal layer made of polylactic acid non-woven fabrics and thin polyurethane
Outer layer made of film.
2. a kind of traditional Chinese medicine plaster of resisting cardiovascular disease as described in claim 1, it is characterised in that: the microballoon includes
Aluminium powder and the polylactic acid shell being coated on outside aluminium powder.
3. a kind of traditional Chinese medicine plaster of resisting cardiovascular disease as claimed in claim 2, it is characterised in that: contain in the aluminium powder
There is solid weak acid, the mass ratio of aluminium powder and solid weak acid is 4 ~ 10:1.
4. a kind of traditional Chinese medicine plaster of resisting cardiovascular disease as described in claim 1 ~ 3 is any, it is characterised in that: described micro-
Ball the preparation method comprises the following steps:
A) according to parts by weight, the acetone soln that solid content is 8 ~ 12wt% is made in 78 ~ 82 parts of polylactic acid under room temperature, be added
0.08 ~ 0.12 part of phosphoric acid, is dispersed with stirring 10 ~ 25min；It is slowly added to while stirring into dispersion liquid at 14 ~ 18 parts of surface
2.4 ~ 2.6 parts of amino resins, 0.4 ~ 0.6 part of organic silicon defoamer and 0.8 ~ 1.0 part of poly- carboxylic is added in the aluminium powder of reason while stirring
Acid dispersant continues to stir 30-120min, obtains the composite dispersion liquid of polymer-coated metal powder；
B) composite dispersion liquid for obtaining step a) is spray-dried, and obtains the microballoon of polymer-coated metal powder.
5. a kind of traditional Chinese medicine plaster of resisting cardiovascular disease as claimed in claim 4, it is characterised in that: in step a), institute
State what the aluminium powder of surface treatment was handled for metal powder by lubricant or/and surfactant, processing method are as follows: by aluminium powder
15 ~ 25min of ultrasonic disperse in the lubricant or/and surfactant solution that concentration is 0.4 ~ 0.6wt% is added, then 55 ~ 65
The mass volume ratio of DEG C 2 ~ 3h of stirring, aluminium powder and lubricant or/and surfactant solution is 1:3 ~ 5；The lubricant is hard
At least one of resin acid, metallic soap and atoleine, the surfactant are neopelex, lecithin and rouge
Fat acid sorb is at least one of smooth；In step b), the intake air temperature of the spray drying is 170-250 DEG C；Air outlet temperature
Degree is 70-100 DEG C.
6. a kind of traditional Chinese medicine plaster of resisting cardiovascular disease as described in claim 1, it is characterised in that: the Chinese medicine and cream
The mass percent of body matrix are as follows: Chinese medicine 19.5 ~ 20.2%, ointment bases 79.8 ~ 80.5%.
7. a kind of traditional Chinese medicine plaster of resisting cardiovascular disease as claimed in claim 6, it is characterised in that: the ointment bases
Composition including following parts by weight: 39 ~ 46 parts of medical thermoplastic elastomer (TPE), 15 ~ 29 parts of medical tackifier, medical softening agent 20
~ 38 parts, 1 ~ 5 part of skin penetration enhancer, load have 4 ~ 7 parts of 7 ~ 10 parts of microballoon, filler zinc oxide, the far-infrared ceramic of aluminium powder
0.6 ~ 1 part of powder, 7 ~ 8 parts and 1 ~ 2 part of antioxidant of magnetic powder.
8. a kind of traditional Chinese medicine plaster of resisting cardiovascular disease as claimed in claim 6, it is characterised in that: the Chinese medicine includes
Following components: 12-14 parts of Radix Angelicae Sinensis, 8-10 parts of Rhizoma Chuanxiong, 8-10 parts of leech, 8-10 parts of Eupolyphoge sinensis, 4-6 parts of radix paeoniae rubra, 4-6 parts of peach kernel, red
Flower 6-8 parts, 12-14 parts of pheretima, 7-9 parts of pueraria lobata, 18-20 parts of the root of Dahurain angelica, 10-12 parts of rhizoma acori graminei, 10-12 parts of Radix Polygalae, rhizoma typhonii 7-9
Part, 5-7 parts of arisaema cum bile, 5-8 parts of bombys batryticatus, wide 200-280 parts and 460-540 parts of vegetable oil of pellet.
9. a kind of traditional Chinese medicine plaster of resisting cardiovascular disease as claimed in claim 7, it is characterised in that: the antioxidant is
Antioxidant BHT；The thermoplastic elastomer is styrenic thermoplastic elastomer, polyester-type thermoplastic rubber, thermoplastic polyurethane
At least one of；The tackifier are natural or synthetic resin, and the natural or synthetic resin is cyclopentadiene, isoamyl two
At least one of alkene, rosin, hydrogenated rosin, hydrogenated rosin glycerolipid；The softening agent is atoleine, lanolin, Huang
At least one of vaseline, vaseline；The skin penetration enhancer includes host agent and adjuvant, and the host agent is N- diformazan ammonia
At least one of base n-butyric acie dodecane ester and bisabolol, ferulic acid and glycerol monopentyl ether, the adjuvant are three pungent
At least one of methyl ammonium and bromo 1- butyl -3- methyl-imidazoles.
10. a kind of traditional Chinese medicine plaster of resisting cardiovascular disease as claimed in claim 8, it is characterised in that: the vegetable oil
For at least one of sesame oil, rapeseed oil, cotton oil.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201811260275.3A CN109464559A (en) | 2018-10-26 | 2018-10-26 | A kind of traditional Chinese medicine plaster of resisting cardiovascular disease |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201811260275.3A CN109464559A (en) | 2018-10-26 | 2018-10-26 | A kind of traditional Chinese medicine plaster of resisting cardiovascular disease |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN109464559A true CN109464559A (en) | 2019-03-15 |
Family
ID=65666154
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201811260275.3A Pending CN109464559A (en) | 2018-10-26 | 2018-10-26 | A kind of traditional Chinese medicine plaster of resisting cardiovascular disease |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN109464559A (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109925184A (en) * | 2019-03-28 | 2019-06-25 | 尹昭军 | A kind of nanometer of thermal sensation massage cream mud ontology, patch, cream and preparation method |
| CN112500839A (en) * | 2020-12-09 | 2021-03-16 | 泰兴瑞深新材科技有限公司 | Preparation method of self-heating express heat insulation material |
| CN113368081A (en) * | 2021-05-24 | 2021-09-10 | 杭州仁德医药有限公司 | A Chinese medicinal patch for treating cerebral thrombosis, and its preparation method |
Citations (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1077893A (en) * | 1992-04-28 | 1993-11-03 | 焦志军 | Preparation method of Dantian heart-strengthening plaster |
| CN1277018A (en) * | 2000-04-11 | 2000-12-20 | 上海伊健实业有限公司 | Far infrared plaster and its preparation |
| CN1491683A (en) * | 2002-10-21 | 2004-04-28 | 马德林 | Chinese medicine adhesive film for preventing and treating coronary heart disease and angina pectoris and its preparing method |
| CN101361975A (en) * | 2008-09-25 | 2009-02-11 | 桂林天和药业股份有限公司 | Medical plaster hot-melt adhesive ground substance, traditional Chinese medicine plaster using the ground substance and preparation method thereof |
| CN101912493A (en) * | 2010-08-19 | 2010-12-15 | 李文奇 | Acupoint plaster for treating cardiovascular and cerebrovascular diseases |
| CN102159257A (en) * | 2008-07-17 | 2011-08-17 | 米歇尔技术公司 | Drug delivery medical device |
| CN102596185A (en) * | 2009-07-29 | 2012-07-18 | 麦德托尼克公司 | An implantable drug depot having a reversible phase transition material for treatment of pain and/or inflammation |
| CN102634307A (en) * | 2012-05-03 | 2012-08-15 | 河南羚锐制药股份有限公司 | Hot-melting pressure sensitive adhesive and preparation method thereof |
| CN103705937A (en) * | 2014-01-09 | 2014-04-09 | 贵州康琦药械有限公司 | Medicinal plaster substrate, medicinal plaster using the substrate and preparation method thereof |
| CN206434472U (en) * | 2016-11-04 | 2017-08-25 | 云南白药集团股份有限公司 | It is a kind of can dosing hot compress paste |
| CN107456548A (en) * | 2017-08-17 | 2017-12-12 | 杭州仁德医药有限公司 | A kind of external plaster for zhuanggu of easing pain |
| CN108030871A (en) * | 2018-02-06 | 2018-05-15 | 重庆医科大学附属永川医院 | A kind of production method of senile hypertension decompression ointment |
| CN108066137A (en) * | 2017-12-08 | 2018-05-25 | 山东木齐健康科技有限公司 | Hydrogen molecule physical therapy plaster and application |
| CN108686217A (en) * | 2017-04-07 | 2018-10-23 | 成都夸常科技有限公司 | A kind of pharmaceutical composition and its application including drug and particulate carrier |
-
2018
- 2018-10-26 CN CN201811260275.3A patent/CN109464559A/en active Pending
Patent Citations (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1077893A (en) * | 1992-04-28 | 1993-11-03 | 焦志军 | Preparation method of Dantian heart-strengthening plaster |
| CN1277018A (en) * | 2000-04-11 | 2000-12-20 | 上海伊健实业有限公司 | Far infrared plaster and its preparation |
| CN1491683A (en) * | 2002-10-21 | 2004-04-28 | 马德林 | Chinese medicine adhesive film for preventing and treating coronary heart disease and angina pectoris and its preparing method |
| CN102159257A (en) * | 2008-07-17 | 2011-08-17 | 米歇尔技术公司 | Drug delivery medical device |
| CN101361975A (en) * | 2008-09-25 | 2009-02-11 | 桂林天和药业股份有限公司 | Medical plaster hot-melt adhesive ground substance, traditional Chinese medicine plaster using the ground substance and preparation method thereof |
| CN102596185A (en) * | 2009-07-29 | 2012-07-18 | 麦德托尼克公司 | An implantable drug depot having a reversible phase transition material for treatment of pain and/or inflammation |
| CN101912493A (en) * | 2010-08-19 | 2010-12-15 | 李文奇 | Acupoint plaster for treating cardiovascular and cerebrovascular diseases |
| CN102634307A (en) * | 2012-05-03 | 2012-08-15 | 河南羚锐制药股份有限公司 | Hot-melting pressure sensitive adhesive and preparation method thereof |
| CN103705937A (en) * | 2014-01-09 | 2014-04-09 | 贵州康琦药械有限公司 | Medicinal plaster substrate, medicinal plaster using the substrate and preparation method thereof |
| CN206434472U (en) * | 2016-11-04 | 2017-08-25 | 云南白药集团股份有限公司 | It is a kind of can dosing hot compress paste |
| CN108686217A (en) * | 2017-04-07 | 2018-10-23 | 成都夸常科技有限公司 | A kind of pharmaceutical composition and its application including drug and particulate carrier |
| CN107456548A (en) * | 2017-08-17 | 2017-12-12 | 杭州仁德医药有限公司 | A kind of external plaster for zhuanggu of easing pain |
| CN108066137A (en) * | 2017-12-08 | 2018-05-25 | 山东木齐健康科技有限公司 | Hydrogen molecule physical therapy plaster and application |
| CN108030871A (en) * | 2018-02-06 | 2018-05-15 | 重庆医科大学附属永川医院 | A kind of production method of senile hypertension decompression ointment |
Non-Patent Citations (3)
| Title |
|---|
| 傅杰，等: "聚合物药物控制释放体系研究进展", 《材料导报》 * |
| 朱传龙: "聚乳酸无纺布的制备及性能研究", 《湖北大学硕士学位论文》 * |
| 潘斌斌，等: "中药新剂型的研究进展", 《湖北中医杂志》 * |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109925184A (en) * | 2019-03-28 | 2019-06-25 | 尹昭军 | A kind of nanometer of thermal sensation massage cream mud ontology, patch, cream and preparation method |
| CN109925184B (en) * | 2019-03-28 | 2024-01-16 | 尹昭军 | Nanometer thermal massage paste body, plaster and preparation method |
| CN112500839A (en) * | 2020-12-09 | 2021-03-16 | 泰兴瑞深新材科技有限公司 | Preparation method of self-heating express heat insulation material |
| CN112500839B (en) * | 2020-12-09 | 2021-10-19 | 上海惠洲实业有限公司 | Preparation method of self-heating express heat insulation material |
| CN113368081A (en) * | 2021-05-24 | 2021-09-10 | 杭州仁德医药有限公司 | A Chinese medicinal patch for treating cerebral thrombosis, and its preparation method |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN109464559A (en) | A kind of traditional Chinese medicine plaster of resisting cardiovascular disease | |
| DE68903048T2 (en) | SHEET MATERIAL FOR A MEDICAL TREATMENT WITH SKIN CONTACT. | |
| CN101700143A (en) | Nano-selenium anion far infrared fabric tight vest for preventing electromagnetic radiation | |
| CN100558389C (en) | A kind of external Chinese medicine for the treatment of burn and preparation method thereof | |
| CN107468840B (en) | External plaster for promoting blood circulation and relieving pain | |
| CN109289008A (en) | A kind of traditional Chinese medicine plaster and preparation method thereof for treating osteoproliferation | |
| CN108294058A (en) | A kind of safety and environmental protection effective, harmless slow-release pesticidal particle and preparation method thereof | |
| CN101366935B (en) | Externally used ultramicro powder traditional Chinese medicine preparation for treating soft tissue injury and preparation method thereof | |
| CN102846426B (en) | Heating paste containing Folium Artemisiae Argyi active component | |
| CN108578056A (en) | Spontaneous heating facial mask and preparation method thereof | |
| CN104623300A (en) | Traditional Chinese medicine for preventing shiver after anesthesia and preparation method of traditional Chinese medicine | |
| KR100907086B1 (en) | Method of producing cosmetic patch comprising the fermented ginseng extracts | |
| CN106235817A (en) | A kind of functional quilt core and processing technique thereof | |
| CN107456548B (en) | External plaster for easing pain and strengthening bones | |
| KR102178353B1 (en) | patch composition for diabetes mellitus and patch manufacturing method using the same | |
| KR102169792B1 (en) | insulin supplying patch composition for diabetes mellitus and patch manufacturing method using the same | |
| CN106798817A (en) | A kind of analgesia ointment production technology | |
| CN105168362A (en) | Breatheasy patch and preparation method thereof | |
| CN107375891B (en) | Preparation method of external plaster for expelling wind-damp | |
| CN107432895B (en) | External plaster for eliminating dampness and relieving pain | |
| CN1810278A (en) | Enteric coated Chinese medicine composition for treating cervical and lumbar spondylopathy | |
| CN108096420A (en) | A kind of antibacterial ointment promoting blood circulation and removing blood stasis and its application | |
| CN108969574A (en) | A kind of heating health Chinese medicine and preparation method thereof | |
| CN107400391A (en) | The both effectiveness nano-health care coating of haze anti electromagnetic wave | |
| KR101154328B1 (en) | manufacturing method of hydrogel patch for treating the athlete's foot |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20190315 |